An Optimization of AAV-82Q-Delivered Rat Model of Huntington's Disease |
So, Kyoung-Ha
(Institute for Stem Cell & Regenerative Medicine (ISCRM), Veterinary Medical Center and College of Veterinary Medicine, Chungbuk National University)
Choi, Jai Ho (Department of Neurosurgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) Islam, Jaisan (Department of Medical Neuroscience, College of Medicine, Chungbuk National University) KC, Elina (Department of Medical Neuroscience, College of Medicine, Chungbuk National University) Moon, Hyeong Cheol (Department of Medical Neuroscience, College of Medicine, Chungbuk National University) Won, So Yoon (Department of Biochemistry and Medical Research Center, Chungbuk National University) Kim, Hyong Kyu (Department of Biochemistry and Medical Research Center, Chungbuk National University) Kim, Soochong (Laboratory of Veterinary Pathology, College of Veterinary Medicine, Chungbuk National University) Hyun, Sang-Hwan (Institute for Stem Cell & Regenerative Medicine (ISCRM), Veterinary Medical Center and College of Veterinary Medicine, Chungbuk National University) Park, Young Seok (Institute for Stem Cell & Regenerative Medicine (ISCRM), Veterinary Medical Center and College of Veterinary Medicine, Chungbuk National University) |
1 | Mangiarini L, Sathasivam K, Mahal A, Mott R, Seller M, Bates GP : Instability of highly expanded CAG repeats in mice transgenic for the Huntington's disease mutation. Nat Genet 15 : 197-200, 1997 DOI |
2 | Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, et al. : Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87 : 493-506, 1996 DOI |
3 | Marini B, Kertesz-Farkas A, Ali H, Lucic B, Lisek K, Manganaro L, et al. : Nuclear architecture dictates HIV-1 integration site selection. Nature 521 : 227-231, 2015 DOI |
4 | Nussbaum RL, McInnes RR, Willard HF : Thompson & Thompson genetics in medicine. Philadelphia : Elsevier Health Sciences, 2015 |
5 | Olsson M, Nikkhah G, Bentlage C, Bjorklund A : Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. J Neurosci 15(5 Pt 2) : 3863-3875, 1995 DOI |
6 | Palfi S, Brouillet E, Jarraya B, Bloch J, Jan C, Shin M, et al. : Expression of mutated huntingtin fragment in the putamen is sufficient to produce abnormal movement in non-human primates. Mol Ther 15 : 1444-1451, 2007 DOI |
7 | Radua J, van den Heuvel OA, Surguladze S, Mataix-Cols D : Metaanalytical comparison of voxel-based morphometry studies in obsessivecompulsive disorder vs other anxiety disorders. Arch Gen Psychiatry 67 : 701-711, 2010 DOI |
8 | Ramaswamy S, McBride JL, Kordower JH : Animal models of Huntington's disease. ILAR J 48 : 356-373, 2007 DOI |
9 | Stack EC, Ferrante RJ : Huntington's disease: progress and potential in the field. Expert Opin Investig Drugs 16 : 1933-1953, 2007 DOI |
10 | Stack EC, Kubilus JK, Smith K, Cormier K, Signore SJD, Guelin E, et al. : Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice. J Comp Neurol 490 : 354-370, 2005 DOI |
11 | Vorisek I, Syka M, Vargova L : Brain diffusivity and structural changes in the R6/2 mouse model of huntington disease. J Neurosci Res 95 : 1474-1484, 2017 DOI |
12 | Wheeler VC, Auerbach W, White JK, Srinidhi J, Auerbach A, Ryan A, et al. : Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouse. Hum Mol Genet 8 : 115-122, 1999 DOI |
13 | White JK, Auerbach W, Duyao MP, Vonsattel JP, Gusella JF, Joyner AL, et al. : Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion. Nat Genet 17 : 404-410, 1997 DOI |
14 | Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, Ross CA, et al. : Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90 : 537-548, 1997 DOI |
15 | Alexander GE, Crutcher MD : Preparation for movement: neural representations of intended direction in three motor areas of the monkey. J Neurophysiol 64 : 133-150, 1990 DOI |
16 | Cattoglio C, Facchini G, Sartori D, Antonelli A, Miccio A, Cassani B, et al. : Hot spots of retroviral integration in human CD34+ hematopoietic cells. Blood 110 : 1770-1778, 2007 |
17 | Ceccarelli I, Fiengo P, Remelli R, Miragliotta V, Rossini L, Biotti I, et al. : Recombinant Adeno Associated Viral (AAV) vector type 9 delivery of Ex1-Q138-mutant huntingtin in the rat striatum as a short-time model for in vivo studies in drug discovery. Neurobiol Dis 86 : 41-51, 2016 DOI |
18 | DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, et al. : Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277 : 1990-1993, 1997 DOI |
19 | Daya S, Berns KI : Gene therapy using adeno-associated virus vectors. Clin Microbiol Rev 21 : 583-593, 2008 DOI |
20 | de Almeida LP, Ross CA, Zala D, Aebischer P, Deglon N : Lentiviralmediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingtin expression levels, and protein length. J Neurosci 22 : 3473-3483, 2002 DOI |
21 | Regulier E, Trottier Y, Perrin V, Aebischer P, Deglon N : Early and reversible neuropathology induced by tetracycline-regulated lentiviral overexpression of mutant huntingtin in rat striatum. Hum Mol Genet 12 : 2827-2836, 2003 DOI |
22 | Reddy PH, Charles V, Williams M, Miller G, Whetsell WO Jr, Tagle DA : Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease. Philos Trans R Soc Lond B Biol Sci 354 : 1035-1045, 1999 DOI |
23 | Reddy PH, Williams M, Charles V, Garrett L, Pike-Buchanan L, Whetsell WO Jr, et al. : Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA. Nat Genet 20 : 198-202, 1998 DOI |
24 | Reddy PH, Williams M, Tagle DA : Recent advances in understanding the pathogenesis of Huntington's disease. Trends Neurosci 22 : 248-255, 1999 DOI |
25 | Sanberg PR, Calderon SF, Giordano M, Tew JM, Norman AB : The quinolinic acid model of Huntington's disease: locomotor abnormalities. Exp Neurol 105 : 45-53, 1989 DOI |
26 | Schilling G, Becher MW, Sharp AH, Jinnah HA, Duan K, Kotzuk JA, et al. : Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum Mol Genet 8 : 397-407, 1999 DOI |
27 | Senut MC, Suhr ST, Kaspar B, Gage FH : Intraneuronal aggregate formation and cell death after viral expression of expanded polyglutamine tracts in the adult rat brain. J Neurosci 20 : 219-229, 2000 DOI |
28 | Shelbourne PF, Killeen N, Hevner RF, Johnston HM, Tecott L, Lewandoski M, et al. : A Huntington's disease CAG expansion at the murine Hdh locus is unstable and associated with behavioural abnormalities in mice. Hum Mol Genet 8 : 763-774, 1999 DOI |
29 | Hodgson JG, Agopyan N, Gutekunst CA, Leavitt BR, LePiane F, Singaraja R, et al. : A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron 23 : 181-192, 1999 DOI |
30 | Foster AC, Whetsell WO Jr, Bird ED, Schwarcz R : Quinolinic acid phosphoribosyltransferase in human and rat brain: activity in Huntington's disease and in quinolinate-lesioned rat striatum. Brain Res 336 : 207-214, 1985 DOI |
31 | Hoth KF, Paulsen JS, Moser DJ, Tranel D, Clark LA, Bechara A : Patients with Huntington's disease have impaired awareness of cognitive, emotional, and functional abilities. J Clin Exp Neuropsychol 29 : 365-376, 2007 DOI |
32 | Hua Y, Schallert T, Keep RF, Wu J, Hoff JT, Xi G : Behavioral tests after intracerebral hemorrhage in the rat. Stroke 33 : 2478-2484, 2002 DOI |
33 | Jang M, Lee SE, Cho IH : Adeno-associated viral vector serotype DJmediated overexpression of N171-82Q-mutant huntingtin in the striatum of juvenile mice is a new model for Huntington's disease. Front Cell Neurosci 12 : 157, 2018 DOI |
34 | Kim M : Brain Transplantation for Huntington Disease. Tissue Eng Regen Med 2 : 322-326, 2005 |
35 | Slow EJ, van Raamsdonk J, Rogers D, Coleman SH, Graham RK, Deng Y, et al. : Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum Mol Genet 12 : 1555-1567, 2003 DOI |
36 | MacDonald ME, Ambrose CM, Duyao MP, Myers RH, Lin C, Srinidhi L et al. : A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 72 : 971-983, 1993 DOI |
![]() |